Haematology
Specimens
The test material is plasma for titration against included and own test erythrocytes.
Examinations
Titration 1. Ref.erythrocyte + ref.method, titration 2. Own testery. + ref. method, titration 3. Ref.erythrocyte + own method, titration 4. Own testery. + own method.
Important Notes
Organised in co-operation with EQUALIS. Participation in all rounds is required. Register orders before the end of December. One round per year.
Microbiology
Specimens
3 plasma samples, 0.7 mL each. Brief case histories also given. Authentic single donor samples.
Examinations
Toxoplasma IgG, IgM and total antibodies, IgG avidity, post-analytical clinical interpretation
Important Notes
Microbiology
Specimens
2 simulated samples
Examinations
Detection of Trichomonas vaginalis antigen and nucleic acid (NAT)
Important Notes
The samples contain hDNA.
Clinical Chemistry
Specimens
2 fresh human serum samples or 2 liquid human samples, 1 ml.
Examinations
Detection of troponin I and troponin T.
Important Notes
Qualitative and quantitative results are processed. This scheme is only for POCT, scheme 2540 is for analysers. If you are not sure whether your device is a POCT meter or an analyser, please contact IEQAS.
Clinical Chemistry
Specimens
2 liquid human serum samples.
Examinations
Tryptase.
Important Notes
Organised in co-operation with UK NEQAS. Participation in all rounds is required. Register orders before the end of October. Limited availability.
Immunology
Specimens
2 plasma or serum samples, 0.4 mL
Examinations
Thyroid stimulating hormone receptor antibodies
Important Notes
Quantitative results are also processed.
Clinical Chemistry
Specimens
2 liquid human serum samples, 2 mL.
Examinations
AFP, CA 125, CA 153, CA 199, CEA, ferritin, hCG (total, intact, beta-subunit), PSA, PSA free, PSA free/total index, TG, TG antibodies, beta-2-microglobulin, NSE, HE4.
Important Notes
2700S is a limited version of the scheme available for laboratories performing testing of 1–5 analytes. Product 2700S does not include reporting from multiple analysers or methods.
Clinical Chemistry
Specimens
2 liquid human serum samples, 2 mL.
Examinations
AFP, CA 125, CA 153, CA 199, CEA, ferritin, hCG (total, intact, beta-subunit), PSA, PSA free, PSA free/total index, TG, TG antibodies, beta-2-microglobulin, NSE, HE4.
Important Notes
2700S is a limited version of the scheme available for laboratories performing testing of 1–5 analytes. Product 2700S does not include reporting from multiple analysers or methods.
Clinical Chemistry
Specimens
1 liquid sample and lyophilised synthetic urine sample containing bacteria
Examinations
Bacterial, erythrocytes and leukocytes counting
Important Notes
Microbiology
Specimens
2 lyophilised samples and dilutor. Brief case histories also given. Pre- and/or post-analytical cases in part of the rounds
Examinations
Culture and quantitation, pre-and/or post-analytical indicators
Important Notes
Scheme 3170 available for urine bacterial screening with automated analysers.
Microbiology
Specimens
2 lyophilised samples and dilutor. Brief case histories also given. The samples intended for susceptibility testing may include both international quality control strains and susceptible or resistant clinical strains. Pre- and/or post-analytical cases in part of the rounds
Examinations
Culture, quantitation, identification and antimicrobial susceptibility testing, pre-and/or post-analytical indicators
Important Notes
Scheme 3170 available for urine bacterial screening with automated analysers.
Clinical Chemistry
Specimens
1 lyophilized urine sample with varying concentrations, 15 mL.
Examinations
Glucose, ketone bodies, leukocytes, nitrite, pH, protein, blood (erythrocytes), relative density.
Important Notes
For clinical laboratories and POCT sites. Water for dissolution available, see scheme 3101, should be ordered separately.